Adbert Alzolay, a right-handed reliever, is set to bolster the Mets' bullpen as he returns from Tommy John surgery. The Mets' decision to sign Alzolay to a two-year minor league deal ahead of the 2025 season was strategic, aiming to have him ready for the 2026 season. Despite undergoing surgery late in the 2024 season, Alzolay demonstrated resilience by pitching four innings in the Venezuelan Winter League post-2025 season. This spring training marks his full recovery, and his option status provides an advantage in the competition. Alzolay's journey began with a major league debut in 2019, showcasing his potential. However, injuries plagued him in 2022 and 2024, impacting his performance. The Mets' strategy is clear: they aim to harness Alzolay's 2023 form, where he excelled as a reliever with a solid strikeout rate and an impressive walk rate. The goal is to replicate the success of Brooks Raley, who recovered from Tommy John surgery and signed a one-year deal with the Mets. Projections indicate Alzolay's potential to pitch around 40 innings with an ERA around 4.0, which would be a significant achievement. The Mets' fans eagerly anticipate Alzolay's performance, and the discussion is open for commenters to share their expectations and insights.
